Pennsylvania 2025_0 Regular Session Status: In Committee Bipartisan · 7 D · 1 R cosponsors

SB 190 — An Act providing for pharmaceutical transparency; establishing the Pharmaceutical Transparency Review Board and providing for its powers and duties; establishing the Pharmaceutical Transparency Review Fund; and imposing a penalty.

Last action — Referred to BANKING AND INSURANCE, Jan. 29, 2025

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill is in committee in the Senate. Introduced January 29, 2025. It must pass committee before a floor vote.

Next likely step: a committee vote, then a floor vote in the Senate.

Prognosis

Advancing 42% · moderate confidence

Where this bill stands today.

Odds of enactment

Low

How often bills like it became law.

  • In Committee

    Current position in the legislative process.

  • 8 sponsors

    1 primary, 7 co-sponsors signed on.

  • Bipartisan support

    Sponsored across 2 parties (7 D · 1 R) — cross-party backing.

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

Summary

Pharmaceutical Transparency

Bill Text

Action History

  1. Referred to BANKING AND INSURANCE, Jan. 29, 2025

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 7 co-sponsors · 245 not signed on

Sponsors (1)

Co-sponsors (7)

Not signed on (245)

245 members have not signed on to this bill.

Show all 245 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does SB 190 do?
Pharmaceutical Transparency
Who sponsors SB 190?
SB 190 is sponsored by Sharif Street (Democratic), Timothy P. Kearney (Democratic), Vincent J. Hughes (Democratic), Jay Costa (Democratic), John I. Kane (Democratic), Judith L. Schwank (Democratic), Daniel Laughlin (Republican), and Maria Collett (Democratic).
What is the current status of SB 190?
This bill is in committee in the Senate. Introduced January 29, 2025. It must pass committee before a floor vote.
Where can I track SB 190?
Track SB 190 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 190

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Stay ahead of SB 190

Last checked for changes 4 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →